Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Heart disease: The largest killer in Australia

According to a new federal government report, heart disease is the biggest killer in Australia, causing nearly 50,000 deaths a year.

16 Mar 2011

Hospitals with higher diagnosis frequency for chronic conditions have lower case-fatality rate

An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as coronary artery disease and kidney failure, according to a study in the March 16 issue of JAMA.

16 Mar 2011

Mile Square earns excellence in heart care

Mile Square Health Center at 2045 W. Washington Blvd. was named an Illinois "Your Healthcare Plus" top performer for excellence in caring for patients with heart failure.

16 Mar 2011

Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels

An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, new Johns Hopkins research suggests.

15 Mar 2011

Cellpraxis, USF Health, UNIFESP present and evaluate ReACT results at scientific meeting

Cellpraxis, USF Health and UNIFESP presented and evaluated the clinical results of an innovative therapy for Refractory Angina patients in a scientific meeting and workshop in São Paulo, Brazil.

15 Mar 2011

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.

14 Mar 2011

Response Biomedical 2010 total revenues decrease to $7,610,827

Response Biomedical Corporation reported that it recorded total revenues of $7,610,827 compared to $9,946,269 in 2009 and reduced operating expenses by 13% to $9,216,257 in 2010 from $10,602,954 in 2009.

11 Mar 2011

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

The Mount Sinai Medical Center has become the first hospital in the United States to perform a cardiac catheterization procedure using the TactiCath force-sensing ablation catheter for the treatment of symptomatic paroxysmal atrial fibrillation, or periodic rapid and irregular heartbeats.

11 Mar 2011

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

10 Mar 2011

Cedars-Sinai earns excellence in 2010 adult heart transplants

The Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed the most adult heart transplants of any U.S. medical center in 2010, according to government statistics released today.

10 Mar 2011

NovaShunt raises Series B financing for CHF 23.7 million

NovaShunt AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23.7 million in a Series B preferred share financing round co-led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund.

9 Mar 2011

State roundup: Mass. effort to manage care for chronically ill; promoting organ donations

For a glimpse of the future of Massachusetts health care as Gov. Deval Patrick envisions it, consider Phyllis Minsky. At 82, Phyllis is complex. Medically, that is. ... Older patients with multiple chronic diseases are the biggest consumers of health care; some 15 percent of Medicare patients make up over 75 percent of health care spending.

8 Mar 2011

AstraZeneca grants $2.5 million to 14 U.S.-based organizations to improve cardiovascular health

The AstraZeneca HealthCare Foundation today announced grants totaling more than $2.5 million to 14 U.S.-based nonprofit organizations from Maine to California dedicated to improving cardiovascular health in local communities.

8 Mar 2011

Scientists discover SNPs linked with high risk of sick sinus syndrome

Scientists at deCODE genetics and academic colleagues from Iceland, The Netherlands, Denmark, USA and Illumina, Inc., today report the discovery of single-letter variants in the sequence of the human genome associated with high risk of sick sinus syndrome.

6 Mar 2011

FDA approves change to prescribing information for Gilead Sciences' Letairis

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.

5 Mar 2011

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Surgeons at University of Utah Hospital have performed the hospital's first implant of a new-generation left ventricular assist device using the HeartWare HVAD. The tiny, partial artificial heart device is being used as part of a national research study for patients with advanced heart failure who are not candidates for heart transplantation.

5 Mar 2011

Doctors at Beaumont Hospital, Troy perform robotic-assisted maze procedure to correct atrial fibrillation

Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery. It's performed through tiny, keyhole incisions with fewer complications and a shorter hospital stay.

4 Mar 2011

Miracor completes PICSO System pilot study in patients with ACS

Miracor Medical Systems GmbH announced today the successful completion of the pilot study of its PICSO System, designed to improve acute coronary syndrome revascularization following primary percutaneous coronary intervention.

4 Mar 2011

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

Palatin Technologies, Inc. today announced that the U.S. Food and Drug Administration has cleared Palatin's request to begin a Phase 2A proof-of-concept human trial under an Investigational New Drug application using a subcutaneously administered formulation of PL-3994, an NPR-A agonist compound, in development for treatment of acute exacerbations of asthma.

4 Mar 2011

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo Pharmaceuticals announced that FORTESTA Gel – recently approved by the U.S. Food and Drug Administration for the treatment of low testosterone, or 'Low T' in adult males – is now available by prescription in pharmacies across the country.

3 Mar 2011

Heart Failure News and Research

Further Reading

Heart disease: The largest killer in Australia

Hospitals with higher diagnosis frequency for chronic conditions have lower case-fatality rate

Mile Square earns excellence in heart care

Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels

Cellpraxis, USF Health, UNIFESP present and evaluate ReACT results at scientific meeting

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

Response Biomedical 2010 total revenues decrease to $7,610,827

First U.S. catheter ablation procedure for treatment of AF performed at Mount Sinai

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

Cedars-Sinai earns excellence in 2010 adult heart transplants

NovaShunt raises Series B financing for CHF 23.7 million

State roundup: Mass. effort to manage care for chronically ill; promoting organ donations

AstraZeneca grants $2.5 million to 14 U.S.-based organizations to improve cardiovascular health

Scientists discover SNPs linked with high risk of sick sinus syndrome

FDA approves change to prescribing information for Gilead Sciences' Letairis

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Doctors at Beaumont Hospital, Troy perform robotic-assisted maze procedure to correct atrial fibrillation

Miracor completes PICSO System pilot study in patients with ACS

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News